Carbohydrate-antigen-125 levels predict hospital stay duration and adverse events at long-term follow-up in Takotsubo cardiomyopathy

Internal and Emergency Medicine

Volumn 11, Issue 5, 2016, Pages 687-694

  Santoro, Francesco ^a   Ferraretti, Armando ^a   Musaico, Francesco ^a   Di Martino, Luigi ^a   Tarantino, Nicola ^a   Ieva, Riccardo ^a   Di Biase, Matteo ^a   Brunetti, Natale Daniele ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Carbohydrate antigen 125; NT pro brain natriuretic peptide; Prognosis; Risk stratification; Takotsubo cardiomyopathy

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CA 125 ANTIGEN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; BLOOD; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; TAKOTSUBO CARDIOMYOPATHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CA-125 ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT OUTCOME ASSESSMENT; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; TAKOTSUBO CARDIOMYOPATHY;

EID: 84978906922     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-016-1393-y     Document Type: Article

References (29)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276
2. Ieva R, Santoro F, Ferraretti A, Spennati G, De Gennaro L, Di Biase M, Brunetti ND (2013) Hyper-acute precipitating mechanism of Tako-Tsubo cardiomyopathy: in the beginning was basal hyperkinesis? Int J Cardiol 167:e55–e57
3. Kosuge M, Ebina T, Hibi K, Morita S, Okuda J, Iwahashi N, Tsukahara K, Nakachi T, Kiyokuni M, Ishikawa T, Umemura S, Kimura K (2010) Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol 55:2514–2516
4. Randhawa MS, Dhillon AS, Taylor HC, Sun Z, Desai MY (2014) Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. J Card Fail. 20:2–8
5. Kang WD, Choi HS, Kim SM (2010) Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. Gynecol Oncol 116:57–60
6. Markman M, Petersen J, Belland A, Burg K (2010) CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial. Oncology 78:1–2
7. Faggiano P, D’Aloia A, Antonini-Canterin F, Vizzardi E, Nicolosi GL, Cas LD (2006) Tumour markers in chronic heart failure. Review of the literature and clinical implications. J Cardiovasc Med 7:573–579
8. Núñez J, Sanchis J, Bodí V, Fonarow GC, Núñez E, Bertomeu-González V, Miñana G, Consuegra L, Bosch MJ, Carratalá A, Chorro FJ, Llàcer A (2010) Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur Heart J 31:1752–1763
9. Prasad A, Lerman A, Rihal CS (2008) Apical ballooning syndrome (Tako- Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 155:408–417
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography (2005) J Am Soc Echocardiogr 18:1440–1463
11. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I, Angina Pectoris-Myocardial Infarction Investigations in Japan (2001) Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol 38:11–18
12. Bast RC, Klug TL, John ES, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887
13. Bates SE (1991) Clinical applications of serum tumor markers. Ann Intern Med 115:623–638
14. Epiney M, Bertossa C, Weil A, Campana A, Bishof P (2000) CA125 production by the peritoneum: in vitro and in vivo studies. Hum Reprod 15:1261–1265
15. Sevinc A, Buyukberger S, Sari R, Kiroglu Y, Turk HM, Ates M (2000) Elevated serum CA125 in hemodialysis patients with peritoneal, pleural or pericardial fluids. Gynecol Oncol 77:254–257
16. Vizzardi E, D’Aloia A, Curnis A (2013) Dei Cas L. Carbohydrate antigen 125: a new biomarker in heart failure. Cardiol Rev. 21:23–26
17. D’Aloia A, Faggiano P, Aurigemma G, Bontempi L, Ruggeri G, Metra M, Nodari S (2003) Dei Cas L. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 41:1805–1811
18. De Gennaro L, Brunetti ND, Montrone D, De Rosa F, Cuculo A, Di Biase M (2012) Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation. Eur J Clin Invest 42:371–375
19. De Gennaro L, Brunetti ND, Bungaro R, Montrone D, Cuculo A, Pellegrino PL, Correale M, Di Biase M (2009) Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome. Coron Artery Dis 20:274–280
20. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321–328
21. Troisi F, Greco S, Brunetti ND, Di Biase M (2008) Right heart dysfunction assessed with echography, B-type natriuretic peptide and cardiopulmonary test in patients with chronic heart failure. J Cardiovasc Med 9:672–676
22. Varol E, Ozaydin M, Dogan A, Kosar F (2005) Tumour marker levels in patients with chronic heart failure. Eur J Heart Fail 7:840–843
23. Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD (2011) N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Am J Cardiol 108:1316–1321
24. Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasad A (2009) Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart 95:1436–1441
25. Ahmed KA, Madhavan M, Prasad A (2012) Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy): comparison with acute myocardial infarction. Coron Artery Dis 23:259–264
26. Akashi YJ, Musha H, Nakazawa K, Miyake F (2004) Plasma brain natriuretic peptide in takotsubo cardiomyopathy. QJM 97:599–607
27. Santoro F, Ieva R, Ferraretti A, Ienco V, Carpagnano G, Lodispoto M, Di Biase L, Di Biase M, Brunetti ND (2013) Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series. Cardiovasc Ther 31:e133–e137
28. Madhavan M, Rihal CS, Lerman A, Prasad A (2011) Acute heart failure in apical ballooning syndrome (TakoTsubo/stress cardiomyopathy): clinical correlates and Mayo Clinic risk score. J Am Coll Cardiol 57:1400–1401
29. Núñez J, Núñez E, Consuegra L, Sanchis J, Bodí V, Martínez-Brotons A, Bertomeu-González V, Robles R, Bosch MJ, Fácila L, Darmofal H, Llàcer A (2007) Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart 93:716–721